04/02/2013
https://congress.gov...
"The cost of developing a drug has doubled, as has the number of clinical trials necessary to file a new drug application."
"I am particularly interested in better understanding what we can do to make it more attractive for companies and venture capitalists to invest."
"To help close this innovation gap, as part of 21st Century Cures Initiative, we must take a fresh look at the challenges facing innovative companies and make certain the right incentives are in place ..."
"We have a huge opportunity to incentivize them."